These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 34399162)

  • 1. Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list.
    Fusaroli M; Raschi E; Contin M; Sambati L; Menchetti M; Fioritti A; Poluzzi E
    Parkinsonism Relat Disord; 2021 Sep; 90():79-83. PubMed ID: 34399162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists.
    Bienfait KL; Menza M; Mark MH; Dobkin RD
    J Clin Neurosci; 2010 Apr; 17(4):539-40. PubMed ID: 20171891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impulse control disorders in Parkinson's disease: a retrospective analysis of 1824 patients in a 12-year period.
    Gunduz A; Çiftçi T; Erbil AC; Senoglu G; Ser MH; Apaydın H
    Neurol Sci; 2024 Jan; 45(1):171-175. PubMed ID: 37581771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease-related disorders in the impulsive-compulsive spectrum.
    Wolters ECh; van der Werf YD; van den Heuvel OA
    J Neurol; 2008 Sep; 255 Suppl 5():48-56. PubMed ID: 18787882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impulse Control and Related Disorders in Parkinson's Disease.
    Weintraub D; Claassen DO
    Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impulsive and compulsive behaviors in Parkinson's disease.
    Evans AH; Strafella AP; Weintraub D; Stacy M
    Mov Disord; 2009 Aug; 24(11):1561-70. PubMed ID: 19526584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impulse control symptoms in patients with Parkinson's disease: The influence of dopaminergic agonist.
    Vargas AP; Vaz LS; Reuter A; Couto CM; Costa Cardoso FE
    Parkinsonism Relat Disord; 2019 Nov; 68():17-21. PubMed ID: 31621612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
    Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M
    Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impulsive-compulsive syndrome in Parkinson's disease].
    Nikitina AV; Fedorova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):32-8. PubMed ID: 23994929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impulse control disorders in Parkinson's disease.
    Marques A; Durif F; Fernagut PO
    J Neural Transm (Vienna); 2018 Aug; 125(8):1299-1312. PubMed ID: 29511827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impulse Control Disorders and Related Complications of Parkinson's Disease Therapy.
    Lopez AM; Weintraub D; Claassen DO
    Semin Neurol; 2017 Apr; 37(2):186-192. PubMed ID: 28511259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System.
    Fusaroli M; Raschi E; Giunchi V; Menchetti M; Rimondini Giorgini R; De Ponti F; Poluzzi E
    Int J Neuropsychopharmacol; 2022 Sep; 25(9):727-736. PubMed ID: 35639870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.
    Seeman P
    Synapse; 2015 Apr; 69(4):183-9. PubMed ID: 25645960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scales to assess impulsive and compulsive behaviors in Parkinson's disease: Critique and recommendations.
    Evans AH; Okai D; Weintraub D; Lim SY; O'Sullivan SS; Voon V; Krack P; Sampaio C; Post B; Leentjens AFG; Martinez-Martin P; Stebbins GT; Goetz CG; Schrag A;
    Mov Disord; 2019 Jun; 34(6):791-798. PubMed ID: 31136681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine agonist serum concentrations and impulse control disorders in Parkinson's disease.
    Staubo SC; Fuskevåg OM; Toft M; Lie IH; Alvik KMJ; Jostad P; Tingvoll SH; Lilleng H; Rosqvist K; Størset E; Odin P; Dietrichs E; Dietrichs ES
    Eur J Neurol; 2024 Feb; 31(2):e16144. PubMed ID: 37955562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Repetitive impulse-associated behavioral disorders in Parkinson's disease].
    Katzenschlager R; Goerlich KS; van Eimeren T
    Nervenarzt; 2012 Dec; 83(12):1582-9. PubMed ID: 22878676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impulse control disorders in Parkinson disease: A cross-sectional study in Morocco.
    El Otmani H; Mouni FZ; Abdulhakeem Z; Attar Z; Rashad L; Saali I; El Moutawakil B; Rafai MA; Slassi I; Nadifi S
    Rev Neurol (Paris); 2019 Apr; 175(4):233-237. PubMed ID: 30935674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impulse control disorders and dopamine dysregulation in Parkinson's disease: a broader conceptual framework.
    Okai D; Samuel M; Askey-Jones S; David AS; Brown RG
    Eur J Neurol; 2011 Dec; 18(12):1379-83. PubMed ID: 21615625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
    Garcia-Ruiz PJ; Martinez Castrillo JC; Alonso-Canovas A; Herranz Barcenas A; Vela L; Sanchez Alonso P; Mata M; Olmedilla Gonzalez N; Mahillo Fernandez I
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):840-4. PubMed ID: 24434037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical spectrum of impulse control disorders in Parkinson's disease.
    Weintraub D; David AS; Evans AH; Grant JE; Stacy M
    Mov Disord; 2015 Feb; 30(2):121-7. PubMed ID: 25370355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.